Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F Dublin, April 29, 2026 (GLOBE NEWSWIRE) -- The "Farm Animal Drugs Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The farm animal drugs market, having shown substantial growth in recent years, is expected to continue its upward trajectory. The market size, projected to rise from $20.66 billion in 2025 to $21.96 billion in 2026 at a CAGR of 6.3%, reflects significant market dynamism. This growth stems from factors such as a burgeoning global livestock population, increased prevalence of infectious animal diseases, and rising demand for animal-derived food products. The expansion of commercial farming and the availability of established veterinary drug classes also contribute significantly.

Looking towards 2030, the market is anticipated to hit $28.88 billion, growing at a CAGR of 7.1%. Key drivers include an increased focus on antimicrobial stewardship and heightened demand for high-quality animal protein. Enhanced veterinary healthcare infrastructure, stringent food safety, and animal welfare regulations further boost growth. Prominent trends in this period involve preventive veterinary medications, combination drug therapies, and a focus on food safety and residue compliance.

The surge in global meat consumption plays a pivotal role in propelling the market forward. As global populations grow and urbanization increases, demands for protein-rich diets skyrocket, consequently elevating the need for veterinary drugs that support livestock health, productivity, and meat quality. For instance, UK meat production saw an increase from 4.05 million tonnes in 2023 to 4.16 million tonnes in 2024, according to Defra.

Leading companies are innovating with solutions like moxidectin injectable treatments for parasite control, which enhance livestock productivity. In March 2023, Norbrook Laboratories Ltd. launched Tauramox, a generic moxidectin solution, after receiving FDA approval. MSD Animal Health's acquisition of Elanco Animal Health's aqua business in July 2024 also exemplifies strategic steps undertaken by major players to enhance their market presence.

Key players in this market include Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., and Elanco Animal Health Incorporated, among others. Notably, the Asia-Pacific region held the largest market share in 2025, with significant activity in countries like China, India, and Japan.

Tariffs have impacted the market by inflating costs for imported active ingredients and finished products, leading to price variations. Nevertheless, these challenges have encouraged domestic manufacturing and API localization, enhancing market stability.

The farm animal drugs market research offers insights into market size, regional shares, and competitive landscapes, facilitating informed business decisions. Farm animal drugs are crucial for disease management in livestock, supporting sustainable practices and food safety standards. Primary drug categories include anti-infectives, parasiticides, and anti-inflammatory agents, utilized through various distribution channels and administration routes.

Key Attributes:

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/e8rb8m

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment